首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1738193

抗核抗体（ANA）检测市场，2025-2029年

Global Antinuclear Antibody Test Market 2025-2029

出版日期: 2025年05月28日 | 出版商:

TechNavio | 英文 207 Pages | 订单完成后即时交付

价格

简介目录图表

抗核抗体 (ANA) 检测市场预计在 2024-2029 年期间将成长 4.339 亿美元，预测期内复合年增长率为 7.3%。

本报告对抗核抗体 (ANA) 检测市场进行了全面的分析，包括市场规模和预测、趋势、成长动力、挑战以及涵盖约 25 家供应商的供应商分析。

该报告提供了当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。市场受到厌氧检测需求不断增长、政府倡议不断增加以及试剂租赁协议数量不断增加的推动。

市场覆盖
基准年	2025
年底	2029
预测期	2025-2029
成长动力	加速度
与前一年同期比较	6.7%
复合年增长率	7.3%
增量金额	4.339亿美元

这项研究客观地结合了一手和二手讯息，并参考了行业主要参与者的意见。报告包含全面的市场规模数据、区域細項分析、供应商格局以及对主要企业的分析。报告同时包含历史数据和预测数据。

研究指出，自体免疫疾病的盛行率不断上升是推动未来几年抗核抗体 (ANA) 检测市场成长的主要原因之一，此外人口成长、医疗保健支出增加以及老年人口增加也将导致市场需求庞大。

地理细分
区域比较
北美：2024-2029 年市场规模及预测
欧洲：2024-2029 年市场规模及预测
亚洲：2024-2029 年市场规模及预测
世界其他地区：2024-2029 年市场规模及预测
美国：市场规模及预测（2024-2029）
德国：2024-2029年市场规模及预测
中国：2024-2029年市场规模及预测
英国：2024-2029 年市场规模及预测
法国：2024-2029年市场规模及预测
加拿大：2024-2029 年市场规模及预测
日本：2024-2029 年市场规模及预测
巴西：2024-2029 年市场规模及预测
义大利：2024-2029 年市场规模及预测
墨西哥：2024-2029 年市场规模及预测
按地区分類的市场机会

第十三章驱动因素、挑战、机会与限制因素

市场驱动因素
市场挑战
驱动因素和挑战的影响
市场机会与限制

第十四章竞争格局

概述
竞争格局
令人困惑的情况
产业风险

第十五章竞争分析

公司简介
企业排名指数
公司市场定位
Abbott Laboratories
Abcam plc
Antibodies Inc.
Bio Rad Laboratories Inc.
BioVision Inc.
Grifols SA
Immuno Concepts Ltd.
Merck KGaA
Orgentec Diagnostika GmbH
Perkin Elmer Inc.
QuidelOrtho Corp.
Seramun Diagnostica GmbH
Thermo Fisher Scientific Inc.
Werfenlife SA
ZEUS Scientific Inc.

第十六章附录

简介目录图表

Product Code: IRTNTR72870

The antinuclear antibody test market is forecasted to grow by USD 433.9 mn during 2024-2029, accelerating at a CAGR of 7.3% during the forecast period. The report on the antinuclear antibody test market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for ana tests, rising government initiatives, and rising number of reagent rental agreements.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	6.7%
CAGR	7.3%
Incremental Value	$433.9 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's antinuclear antibody test market is segmented as below:

By Application

Autoimmune diseases
Infectious diseases

By Technique

Enzyme-linked immunosorbent assay
Indirect immunofluorescence
Multiplex assay
Others

By End-user

Hospitals
Clinical diagnostic laboratories

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing prevalence of autoimmune diseases as one of the prime reasons driving the antinuclear antibody test market growth during the next few years. Also, rising population and healthcare expenditure and increasing geriatric population will lead to sizable demand in the market.

The report on the antinuclear antibody test market covers the following areas:

Antinuclear Antibody Test Market sizing
Antinuclear Antibody Test Market forecast
Antinuclear Antibody Test Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antinuclear antibody test market vendors that include Abbott Laboratories, Abcam plc, Antibodies Inc., Bio Rad Laboratories Inc., BioVision Inc., Grifols SA, Immuno Concepts Ltd., Merck KGaA, Orgentec Diagnostika GmbH, Perkin Elmer Inc., QuidelOrtho Corp., Seramun Diagnostica GmbH, Thermo Fisher Scientific Inc., Transasia Bio Medicals Ltd., Trinity Biotech Plc, Werfenlife SA, and ZEUS Scientific Inc.. Also, the antinuclear antibody test market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Technique
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Antinuclear Antibody Test Market 2019 - 2023
- Historic Market Size - Data Table on Global Antinuclear Antibody Test Market 2019 - 2023 ($ million)
5.2 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.3 Technique segment analysis 2019 - 2023
- Historic Market Size - Technique Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI in global antinuclear antibody test market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Application

8.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
8.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
8.3 Autoimmune diseases - Market size and forecast 2024-2029
- Chart on Autoimmune diseases - Market size and forecast 2024-2029 ($ million)
- Data Table on Autoimmune diseases - Market size and forecast 2024-2029 ($ million)
- Chart on Autoimmune diseases - Year-over-year growth 2024-2029 (%)
- Data Table on Autoimmune diseases - Year-over-year growth 2024-2029 (%)
8.4 Infectious diseases - Market size and forecast 2024-2029
- Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
- Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
- Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
- Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by Technique

9.1 Market segments
- Chart on Technique - Market share 2024-2029 (%)
- Data Table on Technique - Market share 2024-2029 (%)
9.2 Comparison by Technique
- Chart on Comparison by Technique
- Data Table on Comparison by Technique
9.3 Enzyme-linked immunosorbent assay - Market size and forecast 2024-2029
- Chart on Enzyme-linked immunosorbent assay - Market size and forecast 2024-2029 ($ million)
- Data Table on Enzyme-linked immunosorbent assay - Market size and forecast 2024-2029 ($ million)
- Chart on Enzyme-linked immunosorbent assay - Year-over-year growth 2024-2029 (%)
- Data Table on Enzyme-linked immunosorbent assay - Year-over-year growth 2024-2029 (%)
9.4 Indirect immunofluorescence - Market size and forecast 2024-2029
- Chart on Indirect immunofluorescence - Market size and forecast 2024-2029 ($ million)
- Data Table on Indirect immunofluorescence - Market size and forecast 2024-2029 ($ million)
- Chart on Indirect immunofluorescence - Year-over-year growth 2024-2029 (%)
- Data Table on Indirect immunofluorescence - Year-over-year growth 2024-2029 (%)
9.5 Multiplex assay - Market size and forecast 2024-2029
- Chart on Multiplex assay - Market size and forecast 2024-2029 ($ million)
- Data Table on Multiplex assay - Market size and forecast 2024-2029 ($ million)
- Chart on Multiplex assay - Year-over-year growth 2024-2029 (%)
- Data Table on Multiplex assay - Year-over-year growth 2024-2029 (%)
9.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.7 Market opportunity by Technique
- Market opportunity by Technique ($ million)
- Data Table on Market opportunity by Technique ($ million)

10 Market Segmentation by End-user

10.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
10.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
10.4 Clinical diagnostic laboratories - Market size and forecast 2024-2029
- Chart on Clinical diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
- Data Table on Clinical diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
- Chart on Clinical diagnostic laboratories - Year-over-year growth 2024-2029 (%)
- Data Table on Clinical diagnostic laboratories - Year-over-year growth 2024-2029 (%)
10.5 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.11 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.12 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.13 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.14 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
15.5 Abcam plc
- Abcam plc - Overview
- Abcam plc - Product / Service
- Abcam plc - Key news
- Abcam plc - Key offerings
- SWOT
15.6 Antibodies Inc.
- Antibodies Inc. - Overview
- Antibodies Inc. - Product / Service
- Antibodies Inc. - Key offerings
- SWOT
15.7 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
15.8 BioVision Inc.
- BioVision Inc. - Overview
- BioVision Inc. - Product / Service
- BioVision Inc. - Key offerings
- SWOT
15.9 Grifols SA
- Grifols SA - Overview
- Grifols SA - Business segments
- Grifols SA - Key news
- Grifols SA - Key offerings
- Grifols SA - Segment focus
- SWOT
15.10 Immuno Concepts Ltd.
- Immuno Concepts Ltd. - Overview
- Immuno Concepts Ltd. - Product / Service
- Immuno Concepts Ltd. - Key offerings
- SWOT
15.11 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
15.12 Orgentec Diagnostika GmbH
- Orgentec Diagnostika GmbH - Overview
- Orgentec Diagnostika GmbH - Product / Service
- Orgentec Diagnostika GmbH - Key offerings
- SWOT
15.13 Perkin Elmer Inc.
- Perkin Elmer Inc. - Overview
- Perkin Elmer Inc. - Business segments
- Perkin Elmer Inc. - Key offerings
- Perkin Elmer Inc. - Segment focus
- SWOT
15.14 QuidelOrtho Corp.
- QuidelOrtho Corp. - Overview
- QuidelOrtho Corp. - Product / Service
- QuidelOrtho Corp. - Key news
- QuidelOrtho Corp. - Key offerings
- SWOT
15.15 Seramun Diagnostica GmbH
- Seramun Diagnostica GmbH - Overview
- Seramun Diagnostica GmbH - Product / Service
- Seramun Diagnostica GmbH - Key offerings
- SWOT
15.16 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
15.17 Werfenlife SA
- Werfenlife SA - Overview
- Werfenlife SA - Product / Service
- Werfenlife SA - Key offerings
- SWOT
15.18 ZEUS Scientific Inc.
- ZEUS Scientific Inc. - Overview
- ZEUS Scientific Inc. - Product / Service
- ZEUS Scientific Inc. - Key offerings
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

简介目录图表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Technique
Exhibits7: Executive Summary - Chart on Market Segmentation by End-user
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Antinuclear Antibody Test Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Technique Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Application - Market share 2024-2029 (%)
Exhibits39: Data Table on Application - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Application
Exhibits41: Data Table on Comparison by Application
Exhibits42: Chart on Autoimmune diseases - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on Autoimmune diseases - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on Autoimmune diseases - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Autoimmune diseases - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)
Exhibits50: Market opportunity by Application ($ million)
Exhibits51: Data Table on Market opportunity by Application ($ million)
Exhibits52: Chart on Technique - Market share 2024-2029 (%)
Exhibits53: Data Table on Technique - Market share 2024-2029 (%)
Exhibits54: Chart on Comparison by Technique
Exhibits55: Data Table on Comparison by Technique
Exhibits56: Chart on Enzyme-linked immunosorbent assay - Market size and forecast 2024-2029 ($ million)
Exhibits57: Data Table on Enzyme-linked immunosorbent assay - Market size and forecast 2024-2029 ($ million)
Exhibits58: Chart on Enzyme-linked immunosorbent assay - Year-over-year growth 2024-2029 (%)
Exhibits59: Data Table on Enzyme-linked immunosorbent assay - Year-over-year growth 2024-2029 (%)
Exhibits60: Chart on Indirect immunofluorescence - Market size and forecast 2024-2029 ($ million)
Exhibits61: Data Table on Indirect immunofluorescence - Market size and forecast 2024-2029 ($ million)
Exhibits62: Chart on Indirect immunofluorescence - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on Indirect immunofluorescence - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on Multiplex assay - Market size and forecast 2024-2029 ($ million)
Exhibits65: Data Table on Multiplex assay - Market size and forecast 2024-2029 ($ million)
Exhibits66: Chart on Multiplex assay - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Multiplex assay - Year-over-year growth 2024-2029 (%)
Exhibits68: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits69: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits70: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits72: Market opportunity by Technique ($ million)
Exhibits73: Data Table on Market opportunity by Technique ($ million)
Exhibits74: Chart on End-user - Market share 2024-2029 (%)
Exhibits75: Data Table on End-user - Market share 2024-2029 (%)
Exhibits76: Chart on Comparison by End-user
Exhibits77: Data Table on Comparison by End-user
Exhibits78: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits79: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits80: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits81: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits82: Chart on Clinical diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on Clinical diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on Clinical diagnostic laboratories - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Clinical diagnostic laboratories - Year-over-year growth 2024-2029 (%)
Exhibits86: Market opportunity by End-user ($ million)
Exhibits87: Data Table on Market opportunity by End-user ($ million)
Exhibits88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits89: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits90: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits91: Chart on Geographic comparison
Exhibits92: Data Table on Geographic comparison
Exhibits93: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits94: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits95: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits149: Market opportunity By Geographical Landscape ($ million)
Exhibits150: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits151: Impact of drivers and challenges in 2024 and 2029
Exhibits152: Overview on criticality of inputs and factors of differentiation
Exhibits153: Overview on factors of disruption
Exhibits154: Impact of key risks on business
Exhibits155: Companies covered
Exhibits156: Company ranking index
Exhibits157: Matrix on companies position and classification
Exhibits158: Abbott Laboratories - Overview
Exhibits159: Abbott Laboratories - Business segments
Exhibits160: Abbott Laboratories - Key news
Exhibits161: Abbott Laboratories - Key offerings
Exhibits162: Abbott Laboratories - Segment focus
Exhibits163: SWOT
Exhibits164: Abcam plc - Overview
Exhibits165: Abcam plc - Product / Service
Exhibits166: Abcam plc - Key news
Exhibits167: Abcam plc - Key offerings
Exhibits168: SWOT
Exhibits169: Antibodies Inc. - Overview
Exhibits170: Antibodies Inc. - Product / Service
Exhibits171: Antibodies Inc. - Key offerings
Exhibits172: SWOT
Exhibits173: Bio Rad Laboratories Inc. - Overview
Exhibits174: Bio Rad Laboratories Inc. - Business segments
Exhibits175: Bio Rad Laboratories Inc. - Key news
Exhibits176: Bio Rad Laboratories Inc. - Key offerings
Exhibits177: Bio Rad Laboratories Inc. - Segment focus
Exhibits178: SWOT
Exhibits179: BioVision Inc. - Overview
Exhibits180: BioVision Inc. - Product / Service
Exhibits181: BioVision Inc. - Key offerings
Exhibits182: SWOT
Exhibits183: Grifols SA - Overview
Exhibits184: Grifols SA - Business segments
Exhibits185: Grifols SA - Key news
Exhibits186: Grifols SA - Key offerings
Exhibits187: Grifols SA - Segment focus
Exhibits188: SWOT
Exhibits189: Immuno Concepts Ltd. - Overview
Exhibits190: Immuno Concepts Ltd. - Product / Service
Exhibits191: Immuno Concepts Ltd. - Key offerings
Exhibits192: SWOT
Exhibits193: Merck KGaA - Overview
Exhibits194: Merck KGaA - Business segments
Exhibits195: Merck KGaA - Key news
Exhibits196: Merck KGaA - Key offerings
Exhibits197: Merck KGaA - Segment focus
Exhibits198: SWOT
Exhibits199: Orgentec Diagnostika GmbH - Overview
Exhibits200: Orgentec Diagnostika GmbH - Product / Service
Exhibits201: Orgentec Diagnostika GmbH - Key offerings
Exhibits202: SWOT
Exhibits203: Perkin Elmer Inc. - Overview
Exhibits204: Perkin Elmer Inc. - Business segments
Exhibits205: Perkin Elmer Inc. - Key offerings
Exhibits206: Perkin Elmer Inc. - Segment focus
Exhibits207: SWOT
Exhibits208: QuidelOrtho Corp. - Overview
Exhibits209: QuidelOrtho Corp. - Product / Service
Exhibits210: QuidelOrtho Corp. - Key news
Exhibits211: QuidelOrtho Corp. - Key offerings
Exhibits212: SWOT
Exhibits213: Seramun Diagnostica GmbH - Overview
Exhibits214: Seramun Diagnostica GmbH - Product / Service
Exhibits215: Seramun Diagnostica GmbH - Key offerings
Exhibits216: SWOT
Exhibits217: Thermo Fisher Scientific Inc. - Overview
Exhibits218: Thermo Fisher Scientific Inc. - Business segments
Exhibits219: Thermo Fisher Scientific Inc. - Key news
Exhibits220: Thermo Fisher Scientific Inc. - Key offerings
Exhibits221: Thermo Fisher Scientific Inc. - Segment focus
Exhibits222: SWOT
Exhibits223: Werfenlife SA - Overview
Exhibits224: Werfenlife SA - Product / Service
Exhibits225: Werfenlife SA - Key offerings
Exhibits226: SWOT
Exhibits227: ZEUS Scientific Inc. - Overview
Exhibits228: ZEUS Scientific Inc. - Product / Service
Exhibits229: ZEUS Scientific Inc. - Key offerings
Exhibits230: SWOT
Exhibits231: Inclusions checklist
Exhibits232: Exclusions checklist
Exhibits233: Currency conversion rates for US$
Exhibits234: Research methodology
Exhibits235: Information sources
Exhibits236: Data validation
Exhibits237: Validation techniques employed for market sizing
Exhibits238: Data synthesis
Exhibits239: 360 degree market analysis
Exhibits240: List of abbreviations

02-2729-4219

+886-2-2729-4219

License/价格

抗核抗体（ANA）检测市场，2025-2029年

Global Antinuclear Antibody Test Market 2025-2029

目录

第一章执行摘要

第二章 Technavio 分析

第三章市场状况

第四章市场规模

第五章市场规模表现

第六章定性分析

第七章五力分析

第 8 章按应用分類的市场区隔

第九章按技术分類的市场细分

第十章依最终用户细分市场

第十一章客户情况

第十二章地区情势